Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    15288826 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Comparison of Two Antibiotic Regimen (Meropenem Versus Meropenem+Moxifloxacin)in the Treatment of Severe Sepsis and Septic Shock
Conditions: Severe Sepsis;   Septic Shock
Interventions: Drug: meropenem;   Drug: meropenem, moxifloxacin

Indicates status has not been verified in more than two years